Will a blockbuster-level treatment emerge in the hepatitis C treatment market?
Followed by the hepatitis B treatment market, having excellent marketability even allowing a single-substance product to record KRW 150 billion prescriptions, the hepatitis C treatment market has also been accelerated as well.
BMS Korea announced the first domestic oral hepatitis C drug, Daklinz...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
